Boston Sci explains its top-down restructuring

Boston Scientific is shedding more light on a top-down restructuring that has seen it realign or replace more than 75 percent of its top 50 senior managers in the past year. "We've spent a lot of time thinking about what the senior management team needs to be," BSX CFO Jeff Capello said at the Barclay's Capital 2011 Global Healthcare Conference. "The senior management team that's rejuvenated is in place." The company has also realigned its compensation program, reducing short term compensation and creating a broader employee stock purchase program, Capella added. Report

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.